Screening for multiple myeloma

Frank Firkin

Research output: Contribution to journalShort SurveyOtherpeer-review

5 Citations (Scopus)

Abstract

Patients with suspected multiple myeloma should be investigated with screening tests. They may have a paraprotein in the serum, Bence-Jones protein in the urine, or both. If these proteins are detected by a protein electrophoretogram, the patient requires further investigation to distinguish multiple myeloma from monoclonal gammopathy of uncertain significance. Identifying the paraprotein isotype assists in the diagnosis of multiple myeloma, but bone marrow biopsy is needed to show the percentage of plasma cells in the marrow.

Original languageEnglish
Pages (from-to)92-94
Number of pages3
JournalAustralian Prescriber
Volume32
Issue number4
Publication statusPublished - Aug 2009
Externally publishedYes

Keywords

  • Bence-Jones protein
  • Monoclonal gammopathies
  • Paraproteins

Cite this

Firkin, F. (2009). Screening for multiple myeloma. Australian Prescriber, 32(4), 92-94.